CellRight Enters Distribution Agreement with Arthrex
CellRight Technologies signed a long-term, multi-year distribution agreement with Arthrex for CellRight's orthobiologic products for use in orthopaedic, spine and...
Mar 06, 2018,
CellRight Enters Distribution Agreement with Arthrex
Orthofix Cervical-Stim Device Shown to Improve Fusion Rates
Studies show that use of pulsed electromagnetic field treatment after ACDF significantly increased the fusion rate vs. control at 6 and 12 months, for...
Mar 05, 2018, Julie Vetalice
Spineology Receives USPTO Notice for Duo LIF Implant
Spineology received a Notice of Allowance from the USPTO that includes three independent device claims covering the Duo intervertebral implant...
Mar 05, 2018, Julie Vetalice
Bioventus Launches Durolane in the US
Bioventus commenced U.S. launch of DUROLANE single-injection hyaluronic acid to treat knee OA pain. ...
Mar 05, 2018, Julie Vetalice
K2M Posts Revenue Growth Over 9% for 4Q17, 2017
K2M posted 4Q17 revenue of US $67.8MM, +9.7% vs. 4Q16, and 2017 revenue of $258.1MM, +9.1% vs. 2016. ...
Mar 05, 2018, Julie Vetalice
SeaSpine Announces 4Q17, 2017 Revenue
SeaSpine announced 4Q17 revenue of US $34.0MM, +4.5% vs. 4Q16, and 2017 revenue of $131.8MM, +2.3% vs. 2016. ...
Mar 05, 2018, Julie Vetalice
Integra LifeSciences Posts 4Q17, 2017 Revenue
ORTHOWORLD estimates Integra LifeSciences'Â 4Q17 orthopaedic revenue at US $27.42MM, +7.3% from 4Q16, and 2017 revenue of $107.8MM, +8.6% vs. 2016....
Mar 02, 2018, Julie Vetalice
Orthofix Announces 4Q17, 2017 Revenue
Orthofix posted 4Q17 revenue of US $116.9MM, +7.7% from 4Q16, and 2017 revenue of $433.8MM, +5.9% vs. 2016. ...
Mar 02, 2018, Julie Vetalice
Micro C Imaging Adds to its Funding
Micro C Imaging, developer of a portable extremity imaging system, has increased its seed investment to US $2.2MM. ...
Mar 01, 2018, Julie Vetalice
NuVasive Posts 4Q17, 2017 Revenue
NuVasive reported 4Q17 revenue of US $271.7MM, +0.2% vs. 4Q16, and 2017 revenue of $1,029.5MM, +7.0% vs. 2016....
Mar 01, 2018, Julie Vetalice
Loading new posts...
No more posts
